Lupin and Exeltis announce Reimbursement Approval of NaMuscla® in Spain

Lupin Ltd and Exeltis Healthcare S.L announced today that the Spanish Ministry of Health has approved the reimbursement of Lupin's NaMuscla.

Related Keywords

Portugal ,Spain ,Thierry Volle ,Spanish Ministry Of Health ,National Health ,Lupin Limited ,Pharmacy Service ,Reimbursement Approval ,Spanish Ministry ,Director General Spain ,Lupin ,Ine326a01037 ,Exeltishealthcare ,Mscbc ,Reimbursementapproval ,Namuscla ,Mexiletine ,